Header cover image

German (DAX) Biotech Industry Analysis

UpdatedJan 19, 2022
DataAggregated Company Financials
Companies14
  • 7D-5.5%
  • 3M-18.4%
  • 1Y-41.0%
  • YTD-8.6%

Over the last 7 days, the Biotech industry has dropped 5.5%, driven by a pullback from MorphoSys of 8.7%. Meanwhile, BioMark Diagnostics actually outperformed within the industry, gaining 11% in the last week. However, the industry is down 41% over the past year.

Industry Valuation and Performance

Has the German Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Thu, 20 Jan 2022€3.7b€789.6m-€311,283,353.00n/a
Sat, 18 Dec 2021€4.1b€789.6m-€311,690,565.00n/a
Mon, 15 Nov 2021€4.3b€783.5m-€247,037,521.00n/a
Wed, 13 Oct 2021€4.3b€771.2m-€257,628,521.00n/a
Fri, 10 Sep 2021€4.2b€764.3m-€161,273,228.001.3x
Sun, 08 Aug 2021€4.2b€769.4m-€175,243,228.001.4x
Sat, 01 May 2021€5.3b€749.9m-€236,050,839.001.1x
Tue, 02 Feb 2021€6.0b€930.9m-€76,599,954.2333.1x
Fri, 06 Nov 2020€5.0b€857.2m-€136,640,199.0255.3x
Mon, 10 Aug 2020€6.0b€854.0m-€122,928,578.9533.5x
Sun, 03 May 2020€5.3b€860.6m-€123,838,236.3220.5x
Wed, 05 Feb 2020€6.0b€601.6m-€402,351,766.74n/a
Sat, 09 Nov 2019€5.1b€577.4m-€195,098,305.00282.9x
Fri, 02 Aug 2019€5.9b€611.6m-€326,492,610.7639.3x
Mon, 06 May 2019€5.2b€570.3m-€160,055,631.00115x
Thu, 07 Feb 2019€5.2b€573.8m-€164,563,263.0037.4x
PE Ratio

37.4x

Total Market Cap: €5.2bTotal Earnings: -€164,563,263.00Total Revenue: €573.8m0%0%0%3 Year10 Year
202020212022

Current Industry PE: There is insufficient data in this market to determine the PE ratio.

Past Earnings Growth: The earnings for companies in the Biotechs industry have deteriorated over the last three years, while revenues for these companies have grown 11% per year. This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the German Biotech industry?

Biotech-5.54%

Industry PE: There is insufficient data on the sub-industries of this industry.

Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 55% over the next 5 years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
20B BioMark Diagnostics€0.1410.9%
+€1.1m
48.7%PE-12.6x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MOR

€29.03

MorphoSys

7D

-8.7%

1Y

-71.2%

B8F

€1.39

Biofrontera

7D

-5.8%

1Y

-58.6%

MDG1

€2.78

Medigene

7D

-4.8%

1Y

-42.6%

VSCA

€3.10

4SC

7D

-10.3%

1Y

-71.6%

PA8

€1.40

Paion

7D

-14.4%

1Y

-43.2%

FYB

€49.60

Formycon

7D

-2.0%

1Y

-21.0%